MoneyWorks4Me

Aurobindo Pharma informs about press release

22 Jun 2026 Evaluate

Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with receipt of approval by Aurobindo Pharma USA, Inc. (‘Aurobindo USA’), a wholly owned subsidiary of the Company from the U.S. Federal Trade Commission (FTC) to proceed with the acquisition of Lannett Company LLC (‘Lannett’).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..